BioNTech: UK asked deep questions about vaccine

BioNTech's chief commercial officer, Sean Marett, told Associated Press on Wednesday that British authorities h asked extremely "deep questions and detailed questions" before granting company a temporarily license for its COVID-19 vaccine.

He denied that UK decision would divert supply from elsewhere and that company would here to "fair allocation for everyone" and that he hoped company would make a "fair profit...so we can keep in business."

BioNTech confirmed Wednesday y'd won permission for emergency use of ir COVID-19 vaccine in Britain, world's first coronavirus injection that's backed by rigorous science - and a major step toward eventually ending pandemic.

company said its priority w was to begin transporting vaccine to UK as quickly as possible.

approval by Britain's health regulators allows UK to become one of first countries to begin vaccinating its population as it tries to curb Europe's deliest outbreak.